Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9-year experience : prenatal diagnosis in FGFR3 gene

J Assist Reprod Genet. 2009 Aug;26(8):455-60. doi: 10.1007/s10815-009-9339-1. Epub 2009 Sep 30.

Abstract

Purpose: Prenatal diagnosis with ultrasound findings compatible with skeletal dysplasia due to FGFR3 mutations over a 9 year period in pregnancies and abortuses.

Methods: 54 samples were studied. Aneuploidy studies were carried out on all samples. By sequencing analysis, we determined mutations for achondroplasia (ACH), hypochondroplasia (HCH), and type I and type II tanathophoric dysplasia (TD).

Results: 2 chorionic villi samples had a G380R mutation due to a mother with ACH; 4 amniotic fluid samples with TDs in which the foetuses had micromelia plus hypoplastic thoraces; 5 samples from abortuses with TDs. Neither ACH nor HCH occurred in sporadic cases.

Conclusions: Molecular studies in ongoing pregnancies are indicated in cases with an affected parent, a family history with positive molecular studies (maternal anxiety), and when the US finding demonstrates micromelia with a hypoplastic thorax. A protocol for tissues of abortuses should include an X-ray, pathologic anatomy, and genetic studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Diseases, Developmental / complications
  • Bone Diseases, Developmental / diagnosis*
  • Bone Diseases, Developmental / genetics*
  • Chorionic Villi Sampling*
  • DNA / genetics
  • Female
  • Fetus / abnormalities
  • Humans
  • Limb Deformities, Congenital / diagnosis
  • Limb Deformities, Congenital / etiology
  • Point Mutation*
  • Pregnancy
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics*
  • Sequence Analysis, DNA
  • Thorax / abnormalities
  • Time Factors
  • Ultrasonography, Prenatal*

Substances

  • DNA
  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3